Description

Zucca et al reported prognostic factors for males with primary diffuse large cell non-Hodgkin's malignant lymphoma arising in a testis. Patients with diffuse large cell lymphoma of the testis tend to have worse outcomes than diffuse large cell lymphoma arising in other extranodal sites, with a significant rate of CNS relapse. The authors are from the International Extranodal Lymphoma Study Group (IELSG).


 

Parameters:

(1) International Prognostic Index (IPI, see above in 28.07.04)

(2) B symptoms (see above)

(3) chemotherapy type

(4) prophylactic radiotherapy

(5) CNS prophylaxis

 

B-type symptoms: one or more of the following

(1) unexplained, recurrent or sustained fever, with temperature > 38°C

(2) drenching night sweats

(3) weight loss > 10% over the 6 months prior to diagnosis

Parameters

Finding

Points

International Prognostic Index

low (score 0-1)

1

 

low-intermediate (score 2)

1

 

intermediate-high (score 3)

0

 

high (score 4-5)

0

B symptoms

none

1

 

>= 1

0

chemotherapy

anthracycline included

1

 

no anthracycline used

0

prophylactic radiotherapy to contralateral testis

given

1

 

not given

0

CNS prophylaxis

given

1

 

not given

0

 

number of favorable prognostic factors =

= SUM (points for all 5 parameters)

 

Interpretation:

• minimum number of favorable prognostic factors: 0

• maximum number of favorable prognostic factors: 5

• Long term survival was greatest in patients with all 5 favorable prognostic factors.

• Patients who did not receive prophylactic testicular radiation were at risk for disease occurring in the contralateral testis.

• Patients who did not receive CNS prophylaxis were at risk for CNS relapse.

 


To read more or access our algorithms and calculators, please log in or register.